Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ENTERO HEALTHCARE SOLUTIONS LTD.

NSE : ENTEROBSE : 544122ISIN CODE : INE010601016Industry : TradingHouse : Private

BSE1263.2544.8 (+3.68 %)

PREV CLOSE ( ) 1218.45

OPEN PRICE ( ) 1206.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7331

TODAY'S LOW / HIGH ( )1206.05 1268.25

52 WK LOW / HIGH ( )1077.6 1583

NSE1262.2044.8 (+3.68 %)

PREV CLOSE( ) 1217.40

OPEN PRICE ( ) 1221.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1262.20 (3)

VOLUME 89986

TODAY'S LOW / HIGH( ) 1205.70 1268.00

52 WK LOW / HIGH ( )1080 1584.25

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-01 2018

Management Info

Sujesh Vasudevan - Chairman Prabhat Agrawal - Managing Director

Registered Office

Address Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura Road,
Faridabad,
Haryana-121003

Phone 0129-4877300

Email info@enterohealthcare.com

Website www.enterohealthcare.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

23Jun Intimation For Grant Of 5,900 Option
Intimation for grant of 5900 Options pursuant to "Entero Employees Stock..

20Jun Announcement under Regulation 30 (LOD
Intimation for Code of Practices and Procedure for fair disclosure of UPSI

28May Entero Healthcare Solutions gets nod t
Entero Healthcare Solutions has received approval from board of director..

19Mar Entero Healthcare Solutions launches ‘
Entero Healthcare Solutions has launched its ‘HealthEdge’ programme for..

19Mar Entero Healthcare Solutions informs a
Entero Healthcare Solutions has informed that it enclosed a copy of the..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-278.06	191.810000000001
Gross Profit	-356.52	267.800000000001
Operating Profit	139.34	840.23
Net Sales	723.02	4086.7

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Thacker & Co (BSE) 1598.00 (4.65%)	M.Cap ( in Cr)173.82
Omnitex Industries (BSE) 600.85 (5.00%)	M.Cap ( in Cr)252.60
Cravatex (BSE) 520.60 (5.71%)	M.Cap ( in Cr)134.53
Rajesh Power Service (BSE) 1408.95 (1.13%)	M.Cap ( in Cr)2537.15
Chembond Chemicals (BSE) 199.31 (5.00%)	M.Cap ( in Cr)536.08

Shareholding Pattern

	PROMOTERS	52.42%
	NON-INSTITUTION	20.19%
	MUTUAL FUNDS/UTI	6.14%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
HSBC Tax Saver Equi...	0.97
Invesco India Contr...	0.94
Invesco India ELSS ...	0.89
HSBC Consumption Fu...	0.73
Invesco India Small...	0.69
Invesco India Multi...	0.55
Invesco India Aggre...	0.46

Risk Disclosures on Derivatives

Smart Quotes

ENTERO HEALTHCARE SOLUTIONS LTD.